Home
Conditions
Orthomyxoviridae Infections

Clinical trial condition

Orthomyxoviridae Infections

Explore clinical trials studying Orthomyxoviridae Infections. Study availability and eligibility vary by location and protocol.

1,811 public trials 85 recruiting studies

Refine in advanced search Browse all conditions

Orthomyxoviridae Infections trial results

Completed

Probiotic and Influenza Vaccination to Reducing Influenza-like Illness Incident in Elderly

NCT03695432

Conditions: Infections, Influenza, Human, Influenza-like Illness, +5 more
Locations: Integrated Health Post, at Pulo Gadung District Jakarta, DKI Jakarta, Indonesia

View Trial Details

Completed

FluMist in Egg Allergic Patients

NCT01248208

Conditions: Egg Allergy, Egg Hypersensitivity, Eligible for Vaccination Against Influenza, +11 more
Locations: Walter Reed Army Medical Center Washington D.C., District of Columbia, United States

View Trial Details

Completed

An Efficacy Study of GlaxoSmithKline (GSK) Biologicals' Candidate Influenza Vaccine GSK2321138A in Children

NCT01439360

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Dhaka, Bangladesh

GSK Investigational Site Antwerp, Belgium

GSK Investigational Site Antwerp, Belgium

GSK Investigational Site Brussels, Belgium

View all 103 locations

View Trial Details

Completed

Safety and Immunogenicity Study of GSK Biologicals' Seasonal Influenza Candidate Vaccine (GSK2321138A)

NCT01204671

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Chandler, Arizona, United States

GSK Investigational Site Miami, Florida, United States

GSK Investigational Site Newton, Kansas, United States

GSK Investigational Site Lexington, Kentucky, United States

View all 42 locations

View Trial Details

Completed

A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Adults

NCT01144299

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Dresden, Saxony, Germany

GSK Investigational Site Dresden, Saxony, Germany

GSK Investigational Site Dresden, Saxony, Germany

GSK Investigational Site Dresden, Saxony, Germany

View Trial Details

Completed

Trial to Evaluate the Safety and the Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in Healthy Children

NCT01096056

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Seville, Spain

View Trial Details

Completed

Immunogenicity and Safety Study of Fluarix™ Vaccine in Children Who Have Previously Been Vaccinated With Pandemrix™

NCT01196026

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Rotterdam, Netherlands

GSK Investigational Site Karlskrona, Sweden

GSK Investigational Site Malmö, Sweden

GSK Investigational Site Örebro, Sweden

View Trial Details

Completed

Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children

NCT00980005

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Birmingham, Alabama, United States

GSK Investigational Site Benton, Arkansas, United States

GSK Investigational Site Huntington Beach, California, United States

GSK Investigational Site Paramount, California, United States

View all 28 locations

View Trial Details

Completed

Immunogenicity and Safety Study of GSK Biologicals' Influenza Vaccine When Administered in Children

NCT01196988

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Sacramento, California, United States

GSK Investigational Site Boca Raton, Florida, United States

GSK Investigational Site Wichita, Kansas, United States

GSK Investigational Site Wichita, Kansas, United States

View all 59 locations

View Trial Details

Completed

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Monovalent Pandemic H5N1 Vaccine in Adults

NCT01416571

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Mesa, Arizona, United States

View Trial Details

Orthomyxoviridae Infections

Orthomyxoviridae Infections trial results

Related conditions